[Toxic epidermal necrolysis].
Lewerenz
V
V
Hautklinik der Heinrich-Heine-Universität, Düsseldorf.
Bruch-Gerharz
D
D
Ruzicka
T
T
Kruse
R
R
D000284:Administration, Oral; D000287:Administration, Topical; D000328:Adult; D000935:Antifungal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001706:Biopsy; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D003131:Combined Modality Therapy; D003422:Critical Care; D005260:Female; D015725:Fluconazole / Q000009:adverse effects* / Q000627:therapeutic use; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D011239:Prednisolone / Q000008:administration & dosage; D012867:Skin / Q000473:pathology; D013262:Stevens-Johnson Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D014222:Triamcinolone Acetonide / Q000008:administration & dosage
D000935:Antifungal Agents; D005938:Glucocorticoids; D015725:Fluconazole; D011239:Prednisolone; D014222:Triamcinolone Acetonide